Acasti Pharma Inc. ACST
3.37 0.00 (+0.00%)
At closeOct 25, 2024, 4:00 PM EDT
3.20 Day range 3.45
52-week range unavailable
Revenue & Expenses
Latest period ending Mar 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| -12.85M | -52.16M | -15.59M | -16.42M | -24.44M | |
| -12.85M | -42.43M | -9.82M | -19.68M | -25.51M | |
| -1.35 | -5.71 | -1.62 | -7.98 | -14.40 |
Balance sheet
| Fiscal year | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| 23.00M | 27.88M | 30.34M | 50.94M | 14.24M | |
| 73.30M | 79.12M | 128.62M | 62.46M | 22.85M | |
| 11.56M | 11.17M | 20.35M | 6.80M | 9.86M | |
| 61.74M | 67.95M | 108.27M | 55.66M | 12.99M |
Cash flow
| Fiscal year | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| -12.33M | -15.91M | -17.23M | -14.32M | -22.95M | |
| 104.00K | 13.15M | -3.52M | -9.86M | 8.14M | |
| 7.36M | 304.00K | 0 | 59.49M | 13.18M | |
| 89.00K | -17.00K | 0 | -69.00K | -319.00K | |
| -4.87M | -2.46M | -20.60M | 36.70M | -2.63M |